You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
IFNLR1
Interferon lambda receptor 1

Protein Summary
Description
The IFNLR1/IL10RB dimer is a receptor for the cytokine ligands IFNL2 and IFNL3 and mediates their antiviral activity. The ligand/receptor complex stimulate the activation of the JAK/STAT signaling pathway leading to the expression of IFN-stimulated genes (ISG), which contribute to the antiviral state. Determines the cell type specificity of the lambda interferon action. Shows a more restricted pattern of expression in the epithelial tissues thereby limiting responses to lambda interferons primarily to epithelial cells of the respiratory, gastrointestinal, and reproductive tracts. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. The protein encoded by this gene belongs to the class II cytokine receptor family. This protein forms a receptor complex with interleukine 10 receptor, beta ...more
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000327535
  • ENSP00000327824
  • ENSG00000185436
  • ENST00000327575
  • ENSP00000328994
  • ENST00000374418
  • ENSP00000363539
  • ENST00000374421
  • ENSP00000363542

Symbol
  • IL28RA
  • LICR2
  • IFNLR
  • LICR2
  • IL28RA
  • CRF2/12
  • IL-28R1
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
histone modification site profile
0.77
tissue sample
0.63
transcription factor
0.59
tissue
0.56
microRNA
0.52


IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 79.46   (req: < 5)
Gene RIFs: 35   (req: <= 3)
Antibodies: 220   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 79.46   (req: >= 5)
Gene RIFs: 35   (req: > 3)
Antibodies: 220   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 6
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0